Literature DB >> 23549955

Fatal hemorrhagic stroke in a Caucasian girl with moyamoya disease.

Petra Schödel1, Alexander Brawanski, Monika Friedrich, Felix Schlachetzki, Peter Heiss, Karl-Michael Schebesch.   

Abstract

INTRODUCTION: Moyamoya disease (MMD) is an extremely rare neurovascular disorder in Caucasian children. To the best of our knowledge, the aggressive variant including hemorrhagic malignant stroke and consecutive global ischemia has not been reported for this population before. CASE REPORT: We present the case of an 11-year-old girl with sudden neurological deterioration due to intracerebral hemorrhage with early irruption into the ventricular system. MMD with extensive neovascularization was diagnosed by means of computed tomography and magnetic resonance imaging. Despite immediate ventricular drainage, intracranial pressure increased above the mean arterial pressure resulting in malignant bi-hemispheric ischemia. The girl died within 53 h after admission to hospital. DISCUSSION: Intracerebral hemorrhage in young patients is often attributed to vascular malformation. This case shows that MMD may constitute a potential diagnosis in the case of sudden neurological deterioration and loss of consciousness, even in previously healthy children.

Entities:  

Mesh:

Year:  2013        PMID: 23549955     DOI: 10.1007/s00381-013-2089-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  24 in total

Review 1.  Moyamoya disease: a review of histopathology, biochemistry, and genetics.

Authors:  David G Weinberg; Omar M Arnaout; Rudy J Rahme; Salah G Aoun; H Hunt Batjer; Bernard R Bendok
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

2.  Discovery of cerebrovascular moyamoya disease: research during the late 1950s and early 1960s.

Authors:  Hideki Oshima; Yoichi Katayama
Journal:  Childs Nerv Syst       Date:  2012-04       Impact factor: 1.475

3.  Hemorrhage predisposing to cerebral infarction in children with moyamoya disease.

Authors:  Mubeen F Rafay; Sabrina E Smith; Peter Dirks; Derek Armstrong; Gabrielle A deVeber
Journal:  Pediatr Neurol       Date:  2006-05       Impact factor: 3.372

4.  Moyamoya disease--a review.

Authors:  J Suzuki; N Kodama
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

5.  Epidemiological survey of moyamoya disease in Korea.

Authors:  K Ikezaki; D H Han; T Kawano; T Inamura; M Fukui
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

6.  Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy.

Authors:  Jay S Han; Amal Abou-Hamden; Daniel M Mandell; Julien Poublanc; Adrian P Crawley; Joseph A Fisher; David J Mikulis; Michael Tymianski
Journal:  Stroke       Date:  2011-09-08       Impact factor: 7.914

Review 7.  Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures.

Authors:  Joshua R Dusick; Nestor R Gonzalez; Neil A Martin
Journal:  Neurosurgery       Date:  2011-01       Impact factor: 4.654

8.  Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.

Authors:  Shinichi Kuriyama; Yasuko Kusaka; Miki Fujimura; Kenji Wakai; Akiko Tamakoshi; Shuji Hashimoto; Ichiro Tsuji; Yutaka Inaba; Takashi Yoshimoto
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

9.  MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.

Authors:  Anna Rosell; Eloy Cuadrado; Arantxa Ortega-Aznar; Mar Hernández-Guillamon; Eng H Lo; Joan Montaner
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

10.  Clinical features of moyamoya disease in the United States.

Authors:  D Chiu; P Shedden; P Bratina; J C Grotta
Journal:  Stroke       Date:  1998-07       Impact factor: 7.914

View more
  1 in total

Review 1.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.